Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- June 2019
- DOI:
- 10.1371/journal.pone.0216533
- Bibcode:
- 2019PLoSO..1416533P